“Imagine using immune cells to deliver crucial wound-healing agents after a spinal cord injury, or using immune cells to deliver drugs past the blood-brain barrier to treat Parkinson’s or Alzheimer’s disease.
These are the ideas that excite me about science the most. And from where I stand, I see so much promise and opportunity.”
Keynote Speaker
As a keynote speaker Dr. Elizabeth Wayne engages the audience sense of wonder and promise of a future where we can design cures for every disease using out immune system. Her research is at the cutting edge of her field. Her passion to get her findings tested on real human diseases in humans will change the future of cancer therapy.
Consultant
Dr. Wayne runs workshops for small groups on various topics regarding cancer research. Each workshotp is created specifically for each group. She has worked with various groups from graduate students to corporate employees.
STEM and School Visits
Getting to spend time with students at any level, graduate to elementary is Dr. Wayne's favorite part of speaking to audiences about her work and about science. She is invested in increasing diversity in science and encouraging girls and women into STEM fields. She spend as much time as her research and other duties allow visiting schools and universities to talk with students.
Experience
- TED
- National Institutes of Health
- Washington University at St. Louis
- Harvard University
- Cornell University
- California State University at Northridge
- Earlham College
- Mississippi School for Mathematics & Science
- Gordon Research Conferences: Cancer Nanotechnology
- University of North Carolina-Chapel Hill
- Biomedical Engineering Society
I have been honored to speak about my research and about women in science, engineering, and entrepreneurship at academic and government institutions across North America. Below is a list of some of the places I have spoken:
Clients have said:
“When Dr. Wayne walks into the room you know it; her personality is magnetic. It is so exciting to hear about her work and the future of cancer therapies. ”
Experience
